Ifng Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
IFNG is involved in neurodegenerative diseases. This page provides comprehensive information about its function, disease associations, expression patterns, molecular mechanisms, and therapeutic implications.
{{Infobox gene}}
'''IFNG''' (Interferon Gamma) is a critical cytokine that plays central roles in both antiviral immunity and neuroinflammation. It is produced primarily by natural killer cells and T lymphocytes and has complex effects on neurodegenerative processes.
IFN-γ is a homodimeric type II interferon that signals through the IFNGR1/IFNGR2 receptor complex. It is a potent immunomodulator with both pro-inflammatory and immunoregulatory functions.
Key functions:
IFNG expression in the brain:
Induced by:
IFNG signaling:
Therapeutic approaches:
IFN-γ signaling through JAK-STAT pathway is central to its immune modulatory functions. Binding of IFN-γ to its receptor activates JAK1 and JAK2 tyrosine kinases, leading to STAT1 phosphorylation and dimerization. The STAT1 homodimer translocates to the nucleus and binds to GAS (IFN-γ-activated sequence) elements, driving transcription of immune response genes.
IFN-γ also activates interferon regulatory factors (IRFs), particularly IRF1 and IRF8, which orchestrate antigen presentation and immune cell differentiation. IRF1 serves as a transcriptional activator of MHC class I and II molecules, essential for adaptive immune responses.
IFN-γ is a potent microglial activator, inducing MHC class II expression and antigen presentation. Activated microglia release pro-inflammatory cytokines, reactive oxygen species, and nitric oxide, which can be neuroprotective or neurotoxic depending on context.
Chronic IFN-γ exposure contributes to neuronal dysfunction through:
The study of Ifng Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.